Retinoic Acid Embryopathy
- PMID: 29308367
- PMCID: PMC5752814
- DOI: 10.4103/ijabmr.IJABMR_469_16
Retinoic Acid Embryopathy
Abstract
Isotretinoin is a retinoid which is derived from Vitamin A. It is indicated for severe cystic acne treatment, but it has been classified as teratogenic. A wide spectrum of birth defects including craniofacial, heart, and nervous system malformations have been described with prenatal exposure to this drug. We report the case of a newborn with a history of prenatal exposure to isotretinoin with craniofacial defects, including left-sided anotia, right-sided microtia, complex congenital heart disease, and central nervous system malformation.
Keywords: Anotia; central nervous system malformation; congenital heart disease; isotretinoin; microtia; teratogenic.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Wilson RD, Johnson JA, Summers A, Wyatt P, Allen V, Gagnon A, et al. Principles of human teratology: Drug, chemical, and infectious exposure. J Obstet Gynaecol Can. 2007;29:911–26. - PubMed
-
- Jones KL, Jones MC, Campo MD. Smith's recognizable patterns of human malformation. 7th Edition. Elsevier Saunders; 2013. Retinoic Acid Embryopathy; pp. 742–43.
-
- Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, et al. Retinoic acid embryopathy. N Engl J Med. 1985;313:837–41. - PubMed
-
- Dai WS, LaBraico JM, Stern RS. Epidemiology of isotretinoin exposure during pregnancy. J Am Acad Dermatol. 1992;26:599–606. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
